Sardeshmukh Sadanand, Deshmukh Vineeta, Godse Vasanti, Datar Shrinivas, Kulkarni Swapna, Dalvi Sneha, Bhuvad Sushama, Gujar Shweta, Chavan Sandeep
Bharatiya Sanskriti Darshan Trust's Integrated Cancer Treatment and Research Centre, Wagholi, Pune, Maharashtra, India.
Bharatiya Sanskriti Darshan Trust's Integrated Cancer Treatment and Research Centre, Wagholi, Pune, Maharashtra, India.
J Ayurveda Integr Med. 2025 May 21;16(3):100984. doi: 10.1016/j.jaim.2024.100984.
Oral Squamous Cell Carcinoma (OSCC) is the most common type of oral cancer, accounting for 90%-95% of all cancers in the mouth. It is typically noted in individuals over the age of 40, especially men between 60 and 80. However, there has been a recent increase in oral cancer cases among women and younger individuals. We present a case of a 49-year-old female diagnosed with Stage III, moderately differentiated Squamous cell carcinoma of the tongue in August 2005. The patient underwent radiation therapy (35 fractions/70 Gy) and received adjunct chemotherapy (6 cycles of Inj. Cisplatin - LD on October 21, 2005). Despite these treatments, residual induration on the tongue persisted, leading to a Knife biopsy in April 2007 that confirmed the presence of squamous carcinoma infiltrating the lingual muscles. Further, she underwent Wide Excision Glossectomy with Left Supra-Omohyoid Neck Dissection in May 2007 and Total Glossectomy with Hemi mandibulectomy with Left Supra-Omohyoid Neck Dissection in August 2011. In addition to conventional cancer treatments, the patient opted for Ayurvedic treatment at our center, which included a combination of oral Herbo-mineral metallic medicines and detoxifying Panchakarma procedures. The 12-year progression-free survival achieved in this case highlights the potential benefits of combining conventional cancer treatment with personalized adjunct Ayurvedic therapy.
口腔鳞状细胞癌（OSCC）是最常见的口腔癌类型，占口腔所有癌症的90%-95%。它通常在40岁以上的人群中出现，尤其是60至80岁的男性。然而，最近女性和年轻个体中的口腔癌病例有所增加。我们报告一例49岁女性病例，该患者于2005年8月被诊断为III期中度分化的舌鳞状细胞癌。患者接受了放射治疗（35次分割/70 Gy）并接受了辅助化疗（2005年10月21日顺铂注射液低剂量6个周期）。尽管进行了这些治疗，舌部的硬结仍然存在，导致在2007年4月进行了刀检，证实存在浸润舌肌的鳞状癌。此外，她在2007年5月接受了广泛切除舌切除术并进行左肩胛舌骨上颈部清扫术，2011年8月接受了全舌切除术并进行半下颌骨切除术及左肩胛舌骨上颈部清扫术。除了传统的癌症治疗外，患者还在我们中心选择了阿育吠陀治疗，包括口服草药-矿物金属药物和排毒的五种疗法程序。该病例实现的12年无进展生存期凸显了将传统癌症治疗与个性化辅助阿育吠陀疗法相结合的潜在益处。
